Plerixafor

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 996 publications

Cellular context and ligand class shape CXCR4-CCR5 heteromerization in live cells.

Cellular context and ligand class shape CXCR4-CCR5 heteromerization in live cells.

Journal: Research square

Published: June 04, 2026

Clinical Study and Economic Evaluation of High-Dose Etoposide Combined with Mecapegfilgrastim for Autologous Peripheral Blood Stem Cell Mobilization in Patients with Lymphoma

Clinical Study and Economic Evaluation of High-Dose Etoposide Combined with Mecapegfilgrastim for Autologous Peripheral Blood Stem Cell Mobilization in Patients with Lymphoma

Journal: Zhongguo shi yan xue ye xue za zhi

Published: June 02, 2026

CXCR4 coordinates adhesion, migration, and development of human NK cells.

CXCR4 coordinates adhesion, migration, and development of human NK cells.

Journal: bioRxiv : the preprint server for biology

Published: April 29, 2026

Lenalidomide exposure duration and drug holidays do not affect stem cell mobilisation with plerixafor and G-CSF in multiple myeloma.

Lenalidomide exposure duration and drug holidays do not affect stem cell mobilisation with plerixafor and G-CSF in multiple myeloma.

Journal: Leukemia & lymphoma

Published: April 01, 2026

A multi-stage computational pipeline and in vitro validation for the discovery of small-molecule translation inhibitors targeting the bacterial ribosome.

A multi-stage computational pipeline and in vitro validation for the discovery of small-molecule translation inhibitors targeting the bacterial ribosome.

Journal: RSC advances

Published: March 02, 2026

WBC Growth Factors: ASCO Guideline Update.

WBC Growth Factors: ASCO Guideline Update.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 25, 2026

Steady-state mobilization with on-demand plerixafor after CD38 antibody-based induction in multiple myeloma patients.

Steady-state mobilization with on-demand plerixafor after CD38 antibody-based induction in multiple myeloma patients.

Journal: Transfusion

Published: February 24, 2026

Multi-omics reveals a novel Cxcr4+ subpopulation of alveolar macrophages and therapeutic effect of AMD3100 in mice with advanced silicosis.

Multi-omics reveals a novel Cxcr4+ subpopulation of alveolar macrophages and therapeutic effect of AMD3100 in mice with advanced silicosis.

Journal: Clinical and translational medicine

Published: February 22, 2026

Day-4 plerixafor on peripheral blood stem cell collection for autologous transplantation: A retrospective study.

Day-4 plerixafor on peripheral blood stem cell collection for autologous transplantation: A retrospective study.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: February 08, 2026

Stem cell mobilization with plerixafor in pediatric solid tumors patients: a single-center study

Stem cell mobilization with plerixafor in pediatric solid tumors patients: a single-center study

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: February 01, 2026

Feasibility of Salvage Therapy With High-Dose Bendamustine and Rituximab Based on a Series of Two Cases From a Planned Phase II Trial for Relapsed/Refractory Diffuse Large B-cell Lymphoma.

Feasibility of Salvage Therapy With High-Dose Bendamustine and Rituximab Based on a Series of Two Cases From a Planned Phase II Trial for Relapsed/Refractory Diffuse Large B-cell Lymphoma.

Journal: Cureus

Published: January 29, 2026

AMD3100 modulates the secretome responses of human Mesenchymal Stromal Cells but not their inhibitory effect on T cell proliferation.

AMD3100 modulates the secretome responses of human Mesenchymal Stromal Cells but not their inhibitory effect on T cell proliferation.

Journal: Scientific reports

Published: January 19, 2026

Showing 1-12 of 996

Last Updated: 06/30/2026